| Followers | 79 |
| Posts | 3015 |
| Boards Moderated | 0 |
| Alias Born | 12/04/2020 |
Monday, August 25, 2025 11:10:06 AM
Great stuff. We knew this was coming. Big pharma tries to sabotage. When that doesn't work, they try to ignore. When that doesn't work, they start buying companies.
Recent DFTX News
- Form 8-K - Current report • Edgar (US Regulatory) • 05/12/2026 12:15:16 PM
- Definium Therapeutics Announces First Patient Dosed in Ascend, the Second Phase 3 Pivotal Study of DT120 ODT in Major Depressive Disorder • Business Wire • 05/12/2026 11:00:00 AM
- Definium Therapeutics Announces New Employee Inducement Grants • Business Wire • 05/11/2026 08:01:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/07/2026 08:17:29 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/07/2026 08:12:25 PM
- Definium Therapeutics Reports First Quarter 2026 Financial Results and Recent Highlights • Business Wire • 05/07/2026 08:01:00 PM
- Definium Therapeutics to Report First Quarter 2026 Financial Results on May 7, 2026 • Business Wire • 04/30/2026 08:01:00 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 04/27/2026 08:07:02 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/27/2026 08:05:14 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/22/2026 08:22:38 PM
- Definium Therapeutics Highlights DT120 ODT (Lysergide Tartrate) Clinical Advancements and Commercial Strategy at Investor and Analyst Day • Business Wire • 04/22/2026 08:15:00 PM
- Definium Therapeutics Announces New Employee Inducement Grants • Business Wire • 04/20/2026 08:01:00 PM
- Definium Therapeutics Applauds White House Executive Order to Accelerate Mental Health Innovation and Expand Access to Psychedelic Medical Treatments • Business Wire • 04/18/2026 11:38:00 PM
- Definium Therapeutics to Participate at Upcoming Investor Conferences and Events • Business Wire • 04/09/2026 11:00:00 AM
- New Definium Therapeutics Study Published in the Journal of Mood and Anxiety Disorders Reveals Increasing Prevalence and Burden of Generalized Anxiety Disorder in the United States • Business Wire • 03/31/2026 11:00:00 AM
- Definium Therapeutics Announces New Employee Inducement Grants • Business Wire • 03/30/2026 08:01:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/26/2026 10:43:44 PM
- Definium Therapeutics to Host Investor and Analyst Day in New York on April 22, 2026 • Business Wire • 03/26/2026 11:00:00 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/25/2026 09:41:22 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/25/2026 09:40:41 PM
- Definium Therapeutics Announces New Employee Inducement Grants • Business Wire • 03/09/2026 08:01:00 PM
- CNS Drug Developers Add Pharma Veterans as Sector Nears First FDA Decisions • PR Newswire (Canada) • 03/09/2026 02:50:00 PM
- CNS Drug Developers Add Pharma Veterans as Sector Nears First FDA Decisions • PR Newswire (US) • 03/09/2026 02:50:00 PM
- Psychedelic Biotechs Push Toward Phase 3: Five Companies Advancing CNS Treatments • PR Newswire (US) • 02/27/2026 04:44:00 PM
- Psychedelic Biotechs Push Toward Phase 3: Five Companies Advancing CNS Treatments • PR Newswire (Canada) • 02/27/2026 04:44:00 PM
